Matches in SemOpenAlex for { <https://semopenalex.org/work/W974414595> ?p ?o ?g. }
- W974414595 endingPage "539" @default.
- W974414595 startingPage "531" @default.
- W974414595 abstract "Treatment failure in cancer chemotherapy is largely due to the toxic effects of chemotherapeutic agents on normal cells/tissues. The proteasome inhibitor bortezomib has been successfully applied to treat multiple myeloma (MM), but there are some common adverse reactions in the clinic including peripheral neuropathy (PN). The TAK1 selective inhibitor 5Z-7-oxozeaenol has been widely studied in cancer therapy. Here, we investigated the potential synergy of bortezomib and 5Z-7-oxozeaenol in Burkitt's lymphoma (BL) cell lines. Cell viability assay showed that co-treatment of bortezomib at 8 nM, representing a one-eighth concentration for growth arrest, and 5Z-7-oxozeaenol at 2 μM, a dose that exhibited insignificant cytotoxic effects, synergistically induced apoptosis in the cell line Daudi. In parallel with the increasing dose of the bortezomib, and 5Z-7-oxozeaenol at 0.5 μM, lower colony formation efficiencies were seen in the cell line Daudi. Western blotting analysis verified that TAK1 inhibition by 5Z-7-oxozeaenol completely blocked JNK, p38, Erk, IKK, and IκB phosphorylation, which was almost instantly activated by TAK1 both directly or indirectly. Both agents synergistically prevented nuclear translocation of NF-κB, a characteristic of NF-κB inactivation. Moreover, a synergistic effect of bortezomib and 5Z-7-oxozeaenol on Western blotting analysis and flow cytometry was disclosed. Collectively, our results indicated that the proteasome inhibitor bortezomib and the TAK1 inhibitor 5Z-7-oxozeaenol displayed synergy on inhibiting BL cell apoptosis by inhibiting NF-κB activity." @default.
- W974414595 created "2016-06-24" @default.
- W974414595 creator A5000665985 @default.
- W974414595 creator A5008191957 @default.
- W974414595 creator A5016472511 @default.
- W974414595 creator A5018463427 @default.
- W974414595 creator A5024279326 @default.
- W974414595 creator A5029157661 @default.
- W974414595 creator A5037838431 @default.
- W974414595 creator A5068525508 @default.
- W974414595 creator A5068705906 @default.
- W974414595 creator A5075448316 @default.
- W974414595 creator A5081366427 @default.
- W974414595 creator A5083581319 @default.
- W974414595 creator A5088114648 @default.
- W974414595 date "2015-08-01" @default.
- W974414595 modified "2023-09-26" @default.
- W974414595 title "Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi" @default.
- W974414595 cites W1964176593 @default.
- W974414595 cites W1964332439 @default.
- W974414595 cites W1972078736 @default.
- W974414595 cites W1975966958 @default.
- W974414595 cites W1987390357 @default.
- W974414595 cites W1992744008 @default.
- W974414595 cites W1997730506 @default.
- W974414595 cites W2005792688 @default.
- W974414595 cites W2029276835 @default.
- W974414595 cites W2034269086 @default.
- W974414595 cites W2051994734 @default.
- W974414595 cites W2062636299 @default.
- W974414595 cites W2084842992 @default.
- W974414595 cites W2085027690 @default.
- W974414595 cites W2089407373 @default.
- W974414595 cites W2094863064 @default.
- W974414595 cites W2097491315 @default.
- W974414595 cites W2103562758 @default.
- W974414595 cites W2107238027 @default.
- W974414595 cites W2116554142 @default.
- W974414595 cites W2118820477 @default.
- W974414595 cites W2124042268 @default.
- W974414595 cites W2127192057 @default.
- W974414595 cites W2132570074 @default.
- W974414595 cites W2144901028 @default.
- W974414595 cites W2151457918 @default.
- W974414595 cites W2152645133 @default.
- W974414595 cites W2160972799 @default.
- W974414595 cites W2315613727 @default.
- W974414595 cites W26151548 @default.
- W974414595 doi "https://doi.org/10.1007/s13277-015-3832-1" @default.
- W974414595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26227222" @default.
- W974414595 hasPublicationYear "2015" @default.
- W974414595 type Work @default.
- W974414595 sameAs 974414595 @default.
- W974414595 citedByCount "6" @default.
- W974414595 countsByYear W9744145952017 @default.
- W974414595 countsByYear W9744145952019 @default.
- W974414595 crossrefType "journal-article" @default.
- W974414595 hasAuthorship W974414595A5000665985 @default.
- W974414595 hasAuthorship W974414595A5008191957 @default.
- W974414595 hasAuthorship W974414595A5016472511 @default.
- W974414595 hasAuthorship W974414595A5018463427 @default.
- W974414595 hasAuthorship W974414595A5024279326 @default.
- W974414595 hasAuthorship W974414595A5029157661 @default.
- W974414595 hasAuthorship W974414595A5037838431 @default.
- W974414595 hasAuthorship W974414595A5068525508 @default.
- W974414595 hasAuthorship W974414595A5068705906 @default.
- W974414595 hasAuthorship W974414595A5075448316 @default.
- W974414595 hasAuthorship W974414595A5081366427 @default.
- W974414595 hasAuthorship W974414595A5083581319 @default.
- W974414595 hasAuthorship W974414595A5088114648 @default.
- W974414595 hasConcept C104317684 @default.
- W974414595 hasConcept C153911025 @default.
- W974414595 hasConcept C184235292 @default.
- W974414595 hasConcept C185592680 @default.
- W974414595 hasConcept C190283241 @default.
- W974414595 hasConcept C203014093 @default.
- W974414595 hasConcept C27740335 @default.
- W974414595 hasConcept C2776364478 @default.
- W974414595 hasConcept C2777478702 @default.
- W974414595 hasConcept C2778367456 @default.
- W974414595 hasConcept C2779338263 @default.
- W974414595 hasConcept C502942594 @default.
- W974414595 hasConcept C51551487 @default.
- W974414595 hasConcept C53227056 @default.
- W974414595 hasConcept C54355233 @default.
- W974414595 hasConcept C553184892 @default.
- W974414595 hasConcept C55493867 @default.
- W974414595 hasConcept C57074206 @default.
- W974414595 hasConcept C81885089 @default.
- W974414595 hasConcept C85265743 @default.
- W974414595 hasConcept C86803240 @default.
- W974414595 hasConcept C98274493 @default.
- W974414595 hasConceptScore W974414595C104317684 @default.
- W974414595 hasConceptScore W974414595C153911025 @default.
- W974414595 hasConceptScore W974414595C184235292 @default.
- W974414595 hasConceptScore W974414595C185592680 @default.
- W974414595 hasConceptScore W974414595C190283241 @default.
- W974414595 hasConceptScore W974414595C203014093 @default.